selegiline has been researched along with istradefylline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoccini, F; Borsini, F; Cabri, W; Diamantini, G; Minetti, P; Mor, M; Pala, D; Piersanti, G; Riccioni, T; Rivara, S; Stasi, MA; Tarzia, G | 1 |
| Gütschow, M; Heer, J; Hinz, S; Küppers, P; Müller, CE; Schlenk, M; Stössel, A | 1 |
| Akkari, R; Borrmann, T; Brunschweiger, A; Drabczyńska, A; Hockemeyer, J; Kieć-Kononowicz, K; Koch, P; Köse, M; Küppers, P; Müller, CE; Radjainia, H; Schlenk, M | 1 |
| Hauser, RA; Hubble, JP; Truong, DD | 1 |
| Waters, C | 1 |
1 review(s) available for selegiline and istradefylline
| Article | Year |
|---|---|
Other pharmacological treatments for motor complications and dyskinesias.
Topics: Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Dyskinesia, Drug-Induced; Gait; Humans; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Periodicity; Purinergic P1 Receptor Antagonists; Purines; Selegiline | 2005 |
1 trial(s) available for selegiline and istradefylline
| Article | Year |
|---|---|
Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.
Topics: Adenosine A2 Receptor Antagonists; Aged; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Chronic Disease; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Nausea; Parkinson Disease; Purines; Safety; Selegiline; Treatment Outcome | 2003 |
3 other study(ies) available for selegiline and istradefylline
| Article | Year |
|---|---|
Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.
Topics: Caffeine; HEK293 Cells; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Docking Simulation; Monoamine Oxidase Inhibitors; Xanthines | 2013 |
Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
Topics: Adenosine A2 Receptor Antagonists; Animals; Benzothiadiazines; Brain; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; In Vitro Techniques; Isoenzymes; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenylbutyrates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Stereoisomerism; Structure-Activity Relationship; Thiazines | 2013 |
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; CHO Cells; Cricetulus; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Purinergic P1 Receptor Antagonists; Purines; Xanthines | 2013 |